Proactive Investors - Run By Investors For Investors

WeedMD secures processing license for its Strathroy cultivation facility

CEO Keith Merker said that the license represents a key milestone, allowing the cannabis company to scale up downstream capacity in packaging and distribution
cannabis greenhouse
WeedMD is hoping to yield more than 150,000 kg by 2020

WeedMD Inc, the medical cannabis producer, announced Monday that it had received a processing license from Health Canada for its Strathroy operation.

The license is a key step in the company’s ability to scale up production, packaging and distribution of cannabis products from its southwestern Ontario facility.

READ: WeedMD adds 60 acres to expand outdoor capacity in Strathroy

“Our recently announced outdoor production expansion combined with this processing license positions WeedMD with the ability to fully execute on its plans to scale up our downstream capacity in packaging and distribution,” said Keith Merker, CEO of WeedMD in a statement.

“This is another critical milestone that will enable WeedMD to address the current supply bottlenecks being experienced across the Canadian cannabis industry.”

The cannabis company is planning to increase its total yield to more than 150,000 kilograms of greenhouse and outdoor cultivation by 2020. It has applied to Health Canada to expand its Strathroy grow operation to include nearly 100 acres of outdoor cultivation, with an initial 25 acres to come online in 2019.

Shares of WeedMD were trading at C$1.81 in Canada and at US$1.36 in the US on Monday afternoon.

--Updates share price--

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Related Articles

November 02 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use